These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 35419964

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pseudohypoaldosteronism Type II Caused by CUL3 Mutation Presented with Visual Impairment.
    Wang Q, Cao BY, Su C, Li WJ, Gong CX.
    Chin Med J (Engl); 2018 Aug 05; 131(15):1879-1881. PubMed ID: 30058590
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Decreased KLHL3 expression is involved in the pathogenesis of pseudohypoaldosteronism type II caused by cullin 3 mutation in vivo.
    Yoshida S, Araki Y, Mori T, Sasaki E, Kasagi Y, Isobe K, Susa K, Inoue Y, Bomont P, Okado T, Rai T, Uchida S, Sohara E.
    Clin Exp Nephrol; 2018 Dec 05; 22(6):1251-1257. PubMed ID: 29869755
    [Abstract] [Full Text] [Related]

  • 8. CUL3 gene analysis enables early intervention for pediatric pseudohypoaldosteronism type II in infancy.
    Osawa M, Ogura Y, Isobe K, Uchida S, Nonoyama S, Kawaguchi H.
    Pediatr Nephrol; 2013 Sep 05; 28(9):1881-4. PubMed ID: 23689903
    [Abstract] [Full Text] [Related]

  • 9. Characterisation of the Cullin-3 mutation that causes a severe form of familial hypertension and hyperkalaemia.
    Schumacher FR, Siew K, Zhang J, Johnson C, Wood N, Cleary SE, Al Maskari RS, Ferryman JT, Hardege I, Yasmin, Figg NL, Enchev R, Knebel A, O'Shaughnessy KM, Kurz T.
    EMBO Mol Med; 2015 Oct 05; 7(10):1285-306. PubMed ID: 26286618
    [Abstract] [Full Text] [Related]

  • 10. Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.
    Ferdaus MZ, McCormick JA.
    Am J Physiol Renal Physiol; 2018 May 01; 314(5):F915-F920. PubMed ID: 29361671
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Gordon syndrome: The importance of measuring blood pressure in children].
    Bruel A, Vargas-Poussou R, Jeunemaitre X, Labbe A, Merlin E, Bessenay L.
    Arch Pediatr; 2016 Aug 01; 23(8):827-31. PubMed ID: 27369102
    [Abstract] [Full Text] [Related]

  • 14. Rare cause of severe hypertension in an adolescent boy presenting with short stature: Answers.
    Yavas Abali Z, Yesil G, Kirkgoz T, Cicek N, Alpay H, Turan S, Bereket A, Guran T.
    Pediatr Nephrol; 2020 Mar 01; 35(3):405-407. PubMed ID: 31529157
    [No Abstract] [Full Text] [Related]

  • 15. Mutant Cullin causes cardiovascular compromise.
    Luft FC.
    EMBO Mol Med; 2015 Oct 01; 7(10):1254-6. PubMed ID: 26294796
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.
    Ferdaus MZ, Miller LN, Agbor LN, Saritas T, Singer JD, Sigmund CD, McCormick JA.
    JCI Insight; 2017 Dec 21; 2(24):. PubMed ID: 29263298
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Hyperkalemic hypertension-associated cullin 3 promotes WNK signaling by degrading KLHL3.
    McCormick JA, Yang CL, Zhang C, Davidge B, Blankenstein KI, Terker AS, Yarbrough B, Meermeier NP, Park HJ, McCully B, West M, Borschewski A, Himmerkus N, Bleich M, Bachmann S, Mutig K, Argaiz ER, Gamba G, Singer JD, Ellison DH.
    J Clin Invest; 2014 Nov 21; 124(11):4723-36. PubMed ID: 25250572
    [Abstract] [Full Text] [Related]

  • 20. Generation and analysis of a mouse model of pseudohypoaldosteronism type II caused by KLHL3 mutation in BTB domain.
    Lin CM, Cheng CJ, Yang SS, Tseng MH, Yen MT, Sung CC, Lin SH.
    FASEB J; 2019 Jan 21; 33(1):1051-1061. PubMed ID: 30148674
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.